Company
Moderna Inc
MRNA:[TICKER]
Moderna Inc is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
102 stories · page 1 of 2
Dow, S&P 500 snap 3-day losing streak as bonds rally
A rally in government bonds eases pressure on equities
Nasdaq leads rally as Bitcoin closes north of $73K
President Trump said that the US would provide risk insurance and potentially naval escorts for tankers navigating the Persian Gulf to restore crude flows
Moderna picks site for new UK vaccine hub, prompting hundreds of jobs
Moderna has picked a site Oxfordshire to build its new research and development centre, amid aims to produce 250mln vaccines annually in the UK
Moderna rockets as vaccine offers 'new paradigm ' in cancer treatment
"It's a tremendous step forward in immunotherapy"
Moderna Covid booster provides room for encouragement rather than complacency
The US drug developer's largely positive data mirrored similar findings released recently by Pfizer
Moderna revenue falls on lower demand for Covid jabs
Fewer people opting for covid jabs has led to decreased revenue for Moderna
Moderna and Merck ink US$250mln deal to develop world's first cancer vaccine
The US firm exercised and option that will allow to help develop and commercialise the new treatment
Moderna to open new vaccine factory in the UK
The £1bn deal will see the vaccine manufacturer collaborate with the UK government to build a manufacturing facility for messenger RNA vaccines for COVID and flu
Covid-19 cases rise in UK for first time in months
The risk of re-infection was around eight times higher for Omicron variants of Covid-19, compared to the Delta variant
Moderna conducting monkeypox vaccine trials, report
Monkeypox is common in parts of Africa, but very rarely seen elsewhere
Moderna CFO Jorge Gomez exits after just one day in the role
Though Gomez left Moderna after just one day in office, he will still receive his full US$700,000 salary for one year
Moderna expects vaccine sales to increase in the back half of 2022 with fall-winter booster in development
Sales of the Moderna vaccine were $5.9 billion in the first quarter, and the firm projects $21 billion total in 2022
Moderna bucks market slump as it ups forecast for Covid-19 jab revenues
Moderna's fortunes have been transformed by its Covid jab
Moderna in talks with UK government over vaccine research and manufacturing hub
Moderna, which sold 510mln doses of its COVID-19 vaccine in the final nine months of last year, has been long searching for overseas investments with plans in Africa, Canada, and Australia revealed in 2021
Archive
US stocks end sharply lower as Omicron fears rattle markets
At the close, the Dow fell 433 points to 34,932, while the S&P 500 eased 53 points at 4,568 and the tech-heavy Nasdaq slipped 189 points to 14,981
US stocks tank as Omicron concerns, Powell comments spook investors
The new COVID-19 variant, first detected in South Africa, has now been found in more than a dozen countries, causing many nations to restrict travel
Moderna boss predicts existing COVID-19 vaccines will be less effective against Omicron variant
Existing vaccines may need to be modified, which could take months, Stéphane Bancel told the FT
Omicron: All UK adults to get Pfizer or Moderna booster
Shares in Moderna jumped 10% today while Pfizer inched higher
Moderna tumbles after cut to Covid-19 vaccine sales forecast
Bottling capacity is proving a problem said the US pharma
US FDA advisers back Moderna COVID-19 vaccine booster for over-65s and high-risk people
Moderna is seeking authorisation for a 50 micrograms dose for the vaccine booster, which is half of its regular dose
Moderna to supply new batch of Covid vaccine to low-income countries
Prices for the latest order would be at its lowest tier, said the drug group's statement.
Moderna boss predicts pandemic will end within a year
Even those who are not vaccinated will develop natural immunity
Moderna says COVID-19 vaccine works on Delta variant
It also worked on the Beta, Eta and other two first identified in Uganda and Angola
Coronavirus: Moderna says tweaked vaccine works against variants, two BioNTech/Pfizer doses give 95% protection
Moderna also turned its first quarterly profits after the jab delivered US$1.7bn of sales
Moderna boosts investments to reach 3bn doses capacity in 2022
The biotech also raised its 2021 supply forecast to 800mln-1bn doses
Coronavirus: England offers jabs to over-45s after hitting vaccination target, begins Moderna Inc rollout
The government aims to offer all adults a vaccine by the end of July
Archive
Dow tanks 560 points, Nasdaq has worst single-day since October as yield rates rise
Apple, Amazon, Facebook and Alphabet all lost more than 3%
Coronavirus: Pfizer vaccine proves highly effective in real-world study, Moderna eyes 2,000% rise in revenue
Moderna is to start the first phase of clinical trials for the version of the vaccine designed to target the South African variant
Coronavirus: Moderna says jab effective against UK, South African variants, Merck drops candidates after unsuccessful trials
The latest developments in the theme of COVID-19 vaccines
Coronavirus: UK approves Moderna vaccine and to impose negative test for travellers, BioNTech/Pfizer jab may work against new strain
Because of Brexit, the UK is not expected to receive the first Moderna deliveries until April
BioNTech, Moderna say approved COVID-19 vaccines should protect against new strain
Meanwhile, the AstraZeneca/Oxford vaccine may receive approval as early as next week
Coronavirus vaccines: Moderna nears US approval, Valneva starts trials in UK as rollout in full steam
Meanwhile in China, Fosun Pharmaceutical has agreed to buy at least 100mln doses of the Pfizer/BioNTech jab for £450mln
Moderna COVID-19 vaccine described as highly effective by FDA scientists
Unconfirmed reports in the US press suggested the final FDA decision would be announced on Friday.
Moderna starts late-stage COVID-19 vaccine trials on teenagers
In other vaccine news, the EU regulator suffered a cyber-attack and the documents related to the Pfizer/BioNTech jab were accessed
Moderna expected to see US$10-15bn from COVID-19 vaccine sales, says Morgan Stanley
Analysts said the revenue forecasts are priced in the recent rally
Moderna boss says its COVID-19 vaccine should be given to vulnerable
The vulnerable and elderly should get its vaccine says chief executive and healthy people should get another vaccine.
Archive
US stocks rally on Moderna vaccine potential, economic recovery
The Dow and S&P 500 posted all-time closing highs as the Nasdaq lags
Moderna says COVID-19 vaccine candidate is 94.5% effective
An independent safety monitoring board confirmed the statistics based on interim results from a late-stage trial
Which Covid vaccines are in phase III? A look at Moderna Therapeutics and the chasing pack
Moderna’s potential treatment uses a different tactic to traditional vaccines: mRNA
Which COVID-19 vaccines are in phase III? A look at Moderna Therapeutics and the chasing pack
Moderna CMO Tal Zaks explained to Stephen Dubner on the Freakonomics Radio podcast just how and why his team might succeed where others have thus far failed
Coronavirus: Moderna surges as coronavirus vaccine trial takes another step forward
The firm said the vaccine candidate, known as mRNA-1273, was safe and had built up an immune response in all 45 participants in the first phase of clinical trials
Archive
Tesla China Plant Might Have Come to the Rescue Last Quarter
“The lesson learned by now is that TSLA shares tend to ‘work’ when something new has launched,” Jeffrey Osborne, a Cowen Inc. analyst with the equivalent of a sell rating on the stock, said in a report Tuesday. “At this point both the Model